Low-dose Naltrexone (LDN) has been used in the treatment of autoimmune diseases in the USA since 1985, but is relatively new in the United Kingdom and Europe. Despite the fact that the drug is used at a very low dose, the occurrence of significant introductory or long term side effects cannot be excluded.
This method was devised and subsequently developed by the late Dr Bernard Bihari, M.D., a physician from New York, USA who passed away May 16, 2010. Dr Bihari was qualified in Internal Medicine, Psychiatry and Neurology, and we hope to honor him by continuing his pioneering work. (Source: LDN Research Trust)
Low- dose naltrexone holds great promise for the millions of people worldwide with autoimmune diseases or central nervous system disorders. If you would like more information, please call and ask to speak to a compounding pharmacist at (610) 632-8838.